trending Market Intelligence /marketintelligence/en/news-insights/trending/xh7vrmnmo7pypwggzuelkw2 content esgSubNav
In This List

Pernix Therapeutics names chief business officer, lead independent director

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Pernix Therapeutics names chief business officer, lead independent director

Pernix Therapeutics Holdings Inc. promoted Angus Smith to senior vice president, chief business officer and principal financial officer.

Smith joined Pernix in September 2014 as vice president of M&A and corporate finance, and was appointed vice president of business development and strategic planning in July 2016.

The New Jersey-based pharmaceutical company also named John Leone as its lead independent director.

Leone, who joined the Pernix board in November 2017, is currently an operating partner at Madryn Asset Management LP, an investment fund focused on providing capital to healthcare companies.